ProMIS Neurosciences is trading 6.21% down now at $13.14, with no clear company-specific negative catalyst identified for September 21, 2026.
- Its scheduled World Alzheimer’s Day appearance at Nasdaq was announced September 1.
- The next major clinical update remains anticipated in early 2027.
- Broader markets are higher, so the decline is not explained by overall risk sentiment.